Most patients with decompensated cirrhosis who received inadequate prognostic information about their condition reported higher symptom burden and lower HRQOL.

The first generic version of Motegrity has been approved by the Food and Drug Administration and is now available.

Among patients diagnosed with early-onset colorectal cancer in a Texas hospital, most presented with advanced-stage disease.

Young adulthood obesity is associated with greater odds for MASLD, at-risk MASH, and increased liver stiffness measurement.

Researchers have found that patients with high consumption of ultra-processed food have increased risk for hypertension.

In 2020, 9.8% of all incident type 2 diabetes cases and 3.1% of incident cardiovascular disease cases were attributable to sugary drinks.

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID.

The first-ever US FDA guidelines on lead in baby food are under fire from health experts who argue the limits are too lenient.

A gap persists between the need for and receipt of substance use disorder treatment among United States individuals.